Clinical Trials
16 trialsNCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT03643484 2024-02-21
IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy
AstraZeneca
Completed
NCT04715347 2023-07-14
ILD
Manchester University NHS Foundation Trust
Completed
NCT04939558 2023-06-02
CARES
TidalSense
Completed
NCT04061356 2023-04-07
EXHALE 1B
Portsmouth Hospitals NHS Trust
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT01374542 2021-10-01
Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Singapore General Hospital
Completed
NCT04503044 2021-08-03
ILAs in CT Lung Cancer Screening Population
Lahey Clinic
Completed
NCT02879773 2020-02-11
CURVE
Heart of England NHS Trust
Completed
NCT01978171 2018-04-12
PREVENT
Radboud University Medical Center
Completed
NCT03388580 2018-01-04
Predictors for Bronchoalveolar Lavage (BAL) Recovery Rate Derived From Quantified Computed Tomography (qCT)
Universitätsmedizin Mannheim
Completed
NCT00504361 2016-05-02
Q-BC
Weill Medical College of Cornell University
Completed
NCT00362739 2016-04-29
Blood Collection From Individuals With Lung Disease for Genetic Studies
Weill Medical College of Cornell University
Completed
NCT02501668 2015-07-17
The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease
Keimyung University Dongsan Medical Center
Completed